Summary
Cencora, Inc. (formerly AmerisourceBergen Corporation) filed an 8-K on May 5, 2023, to disclose an amendment to its securitization facility. This amendment, specifically the Nineteenth Amendment to the Amended and Restated Receivables Purchase Agreement, primarily impacts the financial covenants related to the company's accounts receivable portfolio. The key changes involve an increase in the maximum allowable three-month average default ratio from 0.50% to 1.00% and the maximum three-month average delinquency ratio from 3.25% to 3.50%.
Key Highlights
- 1Amendment to Securitization Facility: Cencora's subsidiaries entered into the Nineteenth Amendment to their Amended and Restated Receivables Purchase Agreement.
- 2Increased Default Ratio Tolerance: The maximum three-month average default ratio for ARFC's accounts receivable portfolio was increased from 0.50% to 1.00%.
- 3Increased Delinquency Ratio Tolerance: The maximum three-month average delinquency ratio was raised from 3.25% to 3.50%.
- 4Purpose of Facility: The securitization facility provides additional liquidity and funding for ongoing business needs, supported by accounts receivables from pharmaceutical sales.
- 5Facility Size: The facility has a base limit of $1,450 million, with an option to increase by $250 million for seasonal needs.
- 6Guarantor Role: Cencora (as AmerisourceBergen Corporation) serves as the performance guarantor for its subsidiaries' obligations under the facility.
Frequently Asked Questions
The amendment primarily adjusts the financial covenants related to the performance of the company's accounts receivable portfolio. Specifically, it raises the acceptable thresholds for average default and delinquency ratios, providing Cencora with greater flexibility in managing its receivables.
While an increase in allowable default and delinquency ratios might raise questions, it is often a proactive measure to provide greater operational flexibility, especially in fluctuating economic conditions or to accommodate specific business strategies. This filing does not inherently indicate financial distress but rather an adjustment to existing financing terms.
The securitization facility has a base limit of $1,450 million. Additionally, there is an option to increase commitments by $250 million, bringing the potential total to $1,700 million, subject to the approval of participating banks and for seasonal needs.
The key subsidiaries involved are AmerisourceReceivablesFinancialCorporation (ARFC) as the seller, AmerisourceBergen Drug Corporation (ABDC) as the servicer, and ASD Specialty Healthcare, LLC (ASD) as an originator whose receivables are included. MUFG Bank, Ltd. acts as the administrator.